Refractive Consequences of Epiretinal Membrane Surgery (EPIREF)
Primary Purpose
Epiretinal Membrane
Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Vitrectomy
Cataract surgery
Combined surgery
Sponsored by
About this trial
This is an interventional treatment trial for Epiretinal Membrane
Eligibility Criteria
Inclusion criteria:
- A diagnosis of Epiretinal membrane,
- visual complaints consistent with Epiretinal membrane,
- age more than 50 years,
- refraction less than ± 5 diopters and astigmatism less than 3 diopters,
- indication for vitrectomy is only Epiretinal membrane.
Exclusion criteria:
- Previous intraocular surgery or laser-refractive procedure.
- Use of intraocular gas tamponade during the vitrectomy.
- Intraoperative manipulation of the intraocular lens.
- Serious complications (endophthalmitis, vitreous haemorrhage or retinal detachment).
- History of previous head or ocular trauma.
- Sulcus fixation of intraocular lens
Sites / Locations
- Eye Department Glostrup Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Active Comparator
Arm Label
Start cataract
start vitrectomy
combined surgery
Arm Description
Patients start having cataract surgery. After one month they undergo vitrectomy
Patients start having vitrectomy. After one month they undergo cataract surgery.
Combined cataract surgery and vitrectomy at the same time
Outcomes
Primary Outcome Measures
Refractive Error
Prediction error of intraocular lens calculation (measured in diopters)
Corneal endothelial count
measured in number of cells per square millimeter (mm2)
Macula anatomy
Macula-anatomy success of surgery, i.e. the postoperative decrease of macula thickness or postoperative macular oedema. Measured in millimeter.
Secondary Outcome Measures
Anterior Chamber Depth
measured in millimeter (mm)
Axial length
measured in millimeter (mm)
Full Information
NCT ID
NCT02413619
First Posted
March 27, 2015
Last Updated
November 9, 2016
Sponsor
Glostrup University Hospital, Copenhagen
1. Study Identification
Unique Protocol Identification Number
NCT02413619
Brief Title
Refractive Consequences of Epiretinal Membrane Surgery
Acronym
EPIREF
Official Title
Refractive Consequences of Epiretinal Membrane Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
November 2016
Overall Recruitment Status
Completed
Study Start Date
May 2014 (undefined)
Primary Completion Date
October 2016 (Actual)
Study Completion Date
October 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Glostrup University Hospital, Copenhagen
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Epiretinal membrane is treated with vitrectomy and peeling. Afterwards cataract is usually developed, which requires a cataract surgery.
The aim of this study is to investigate the refractive consequences of surgery for Epiretinal membrane and cataract.
Investigators investigate the sequence of surgery in patients having surgery for Epiretinal membrane and cataract in a prospective clinically randomized intervention trial. Patients are randomized to 1) start with vitrectomy, 2) start with cataract surgery, 3) combined surgery. Investigators want to find the sequence of surgery that gives the most optimal refractive result, the most stabile intraocular lens, and the minimal loss of corneal endothelial cells.
Detailed Description
Aim: To evaluate the impact of the sequence of surgery on the Refractive Error and the Corneal Endothelial Count in phakic individuals undergoing surgery for Epiretinal membrane.
Study design: Prospective interventional randomized clinical trial. Primary outcome: Refractive error (i.e. Intraocular lens power prediction error), Corneal Endothelial Count, and postoperative macular oedema.
Secondary outcome: Changes in axial length, anterior chamber depth and keratometry; the accuracy of formulas used to calculate the power of the intraocular lens.
Study population:
Identification of participants: Individuals referred to the Macular Surgery Clinic, Surgical Retina Team, Department of Ophthalmology, Glostrup University Hospital, Copenhagen, Denmark. The individuals should be signed up for surgery because of Epiretinal membrane at the clinic.
Method:
Individuals are randomized to the possible sequences of surgery (i.e. start with cataract surgery, start with vitrectomy, or combined surgery). Based on an estimated clinical relevant refractive prediction error of 0,50 diopter and a standard deviation of 0,50 diopter, a number of 20 individuals in each of the three groups are needed to obtain a power of 80 % and a type 1 error of 5 %. Total number of individuals is thus 60.
Clinical examinations are performed preoperatively and 2 weeks after each surgery (cataract surgery, vitrectomy or combined surgery), and 3 and 12 months postoperatively. The examinations include best corrected distance visual acuity, autorefraction/keratometry (Retinomax®, Nikon, Tokyo, Japan), subjective refraction, slit-lamp examination, fundoscopy and tonometry. Biometry by IOLMaster (Carl Zeiss, Meditec AG, Germany), intraocular power calculation with the SRK/T formula. Pentacam Scheimpflug Cornea tomography (Topcon, Tokyo, Japan). Corneal Endothelial Count obtained by three images of the central region of the corneal endothelium (Topcon SP-3000P, Tokyo, Japan). Heidelberg Optical Coherence Tomography, (Heidelberg Engineering, Heidelberg, Germany).
Sequence of surgery depends on randomization. In all cases a standard phacoemulsification (scleral tunnel or clear corneal incision) with in-the-bag intraocular lens implantation. In combined surgery, the cataract surgery is performed before vitrectomy during the same session. Vitreoretinal procedures include a standard three-port 23 gauge pars plana vitrectomy, membrane peeling, and the use of dyes. Cataract surgery is performed by one of two experienced surgeons, and vitrectomy is carried out by one experienced surgeon.
Analysis: A computer database will be created as a fill-in form to record all patient data, and a masked statistical analysis of all outcome measures will be performed. Statistical analysis will be performed to determine differences in baseline data among the three groups (age, sex, visual acuity, keratometry, axial length, anterior chamber depth, Corneal Endothelial Count). To identify independent predictors for all outcome measures at different follow-up times, multivariate regression analysis is performed. All calculations will be performed using SAS software.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Epiretinal Membrane
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
62 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Start cataract
Arm Type
Active Comparator
Arm Description
Patients start having cataract surgery. After one month they undergo vitrectomy
Arm Title
start vitrectomy
Arm Type
Active Comparator
Arm Description
Patients start having vitrectomy. After one month they undergo cataract surgery.
Arm Title
combined surgery
Arm Type
Active Comparator
Arm Description
Combined cataract surgery and vitrectomy at the same time
Intervention Type
Procedure
Intervention Name(s)
Vitrectomy
Intervention Description
Vitrectomy
Intervention Type
Procedure
Intervention Name(s)
Cataract surgery
Intervention Description
Cataract surgery
Intervention Type
Procedure
Intervention Name(s)
Combined surgery
Intervention Description
Combined vitrectomy and cataract surgery at the same time
Primary Outcome Measure Information:
Title
Refractive Error
Description
Prediction error of intraocular lens calculation (measured in diopters)
Time Frame
One year
Title
Corneal endothelial count
Description
measured in number of cells per square millimeter (mm2)
Time Frame
One year
Title
Macula anatomy
Description
Macula-anatomy success of surgery, i.e. the postoperative decrease of macula thickness or postoperative macular oedema. Measured in millimeter.
Time Frame
One year
Secondary Outcome Measure Information:
Title
Anterior Chamber Depth
Description
measured in millimeter (mm)
Time Frame
One year
Title
Axial length
Description
measured in millimeter (mm)
Time Frame
One year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
A diagnosis of Epiretinal membrane,
visual complaints consistent with Epiretinal membrane,
age more than 50 years,
refraction less than ± 5 diopters and astigmatism less than 3 diopters,
indication for vitrectomy is only Epiretinal membrane.
Exclusion criteria:
Previous intraocular surgery or laser-refractive procedure.
Use of intraocular gas tamponade during the vitrectomy.
Intraoperative manipulation of the intraocular lens.
Serious complications (endophthalmitis, vitreous haemorrhage or retinal detachment).
History of previous head or ocular trauma.
Sulcus fixation of intraocular lens
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hassan Hamoudi, MD
Organizational Affiliation
Eye Department Glostrup Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Eye Department Glostrup Hospital
City
Glostrup
State/Province
DK
ZIP/Postal Code
2600
Country
Denmark
12. IPD Sharing Statement
Learn more about this trial
Refractive Consequences of Epiretinal Membrane Surgery
We'll reach out to this number within 24 hrs